<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A portion of anticardiolipin antibodies is defined as <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta 2-GPI) antibodies and recognizes the conformationally altered beta 2 GPI which interacts with anionic <z:chebi fb="1" ids="16247">phospholipids</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the clinical significance of IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent anti-beta 2-GPI antibodies in patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) </plain></SENT>
<SENT sid="2" pm="."><plain>The subjects consisted of 60 APS patients </plain></SENT>
<SENT sid="3" pm="."><plain>IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent anti-beta 2-GPI antibodies were detected by ELISA in 32 of the 60 patients (53%) </plain></SENT>
<SENT sid="4" pm="."><plain>Significantly higher incidences of prolonged APTT and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> were found in patients with these anti-beta 2-GPI antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, significantly lower incidences of malar <z:e sem="disease" ids="C0015230" disease_type="Disease or Syndrome" abbrv="">rash</z:e>, serositis, LE cell preparation and anti-Sm antibodies were found in patients with these anti-beta 2-GPI antibodies </plain></SENT>
<SENT sid="6" pm="."><plain>It was found that 88% of the patients with these anti-beta 2-GPI antibodies satisfied less than five of the revised criteria items for the classification of SLE </plain></SENT>
<SENT sid="7" pm="."><plain>These findings indicate the clinical characteristics of APS patients with IgG <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-dependent anti-beta 2-GPI antibodies </plain></SENT>
</text></document>